10Beachey-Newman N. Sentinel node biopsy : a revolution in the surgical management of breast cancer[ J]. Cancer Treat Rev, 1998,24(3) :185-203.
二级参考文献51
1[1]Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinellymph node in breast cancer[ J]. Cancer, 1997,349:1668～1669.
2[2]Tumer RR, Ollila DW, Krasne DI. Histologic validation of the sentinel lymphnode hypothesis for breast carcinoma[J] .Ann Surg, 1997,226:271～278.
3[3]Morton DI, Wen DR, Wong JH,et al. Technical details of intraoperative lym-phatic mapping for early stage melanoma[J]. Arch Surg, 1992, 127:392～399.
4[4]Thompson Jf, Uren RF,Shaw HM,et al. The location of sentinel lymph nodesin patients with cutaneous melanoma: new insights into lymphatic anatomy[j]. j Am Coll Surg, 1999, l89:195～206.
5[5]Krag DN,Ashikaga T,Harlow SP,et al. Development of sentinel node target-ing technique in breast cancer patients[J]. Breast J,1998,4:67～74.
6[6]Uren RF, Howman - Giles R, Thompson JF, et al. Lymphoscintigraphy to i-dentify sentinal lymph nodes in patients with melanoma[J]. Melanoma Res,1994,4:359～399.
7[7]Balch CM, Ross M, Soong S, et al. The Intergronp Melanoma Conmittee.Longtenn Results of a prospective randomized trial involving elective regionallymph dissection in patients with intermediate thickness melanomas. Presentedat the 52nd annual cancer symposium, Society of Surgical Oncology. Orlando,Fl.March 5,1999.
8[8]Fisher ER, Sass R, Fisher B. Pathologic findings from the National surgicalAdjuvant Project for Breast Cancers (protocol no.4). X. Discriminants fortenth year treatment failure[J]. Cancer, 1984,53:712～723.
9[9]Sacre RA. Clinical evaluation of axillary lymph nodes compared to surgicaland pathological findings[J]. Eur J Surg Oncol, 1986,12:169～173.
10[10]Fisher B. Wolmark W, Bauer M, et al. The accuracy of clinical nodal stagingand of limited axillary dissection as a determinant of histologic nodal status incarcinoma of the breast[J] .Surg Gynecol Obster, 1981,152:765～772.
